We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Johnson & Johnson, Alibaba, Netflix, Qualcomm and Enbridge
Read MoreHide Full Article
For Immediate Release
Chicago, IL – October 5, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Johnson & Johnson (JNJ - Free Report) , Alibaba Group Holding Limited (BABA - Free Report) , Netflix, Inc. (NFLX - Free Report) , QUALCOMM Incorporated (QCOM - Free Report) and Enbridge Inc. (ENB - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for J&J, Alibaba and Netflix
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, Alibaba, and Netflix. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of Johnson & Johnson have underperformed the Zacks Large Cap Pharmaceuticals industry over the year-to-date period (+1.9% vs. +8.0%). J&J faces numerous lawsuits, which allege personal injuries to patients caused by the use of its products. The Zacks analyst believes that these lawsuits have resulted in uncertainties.
However, J&J’s diversification makes it relatively resilient amid macroeconomic turmoil. The Pharma unit is performing at above-market levels, supported by increased penetration and new indications of blockbuster drugs, Imbruvica, Darzalex and Stelara.
Its Medical Devices segment is also demonstrating a strong recovery after its sales were hurt in the early stages of the pandemic. J&J is also making rapid progress with its pipeline and line extensions.
Shares of Alibaba have underperformed the Zacks Internet – Commerce industry over the year-to-date period (-38.0% vs. -30.9%). The Zacks analyst believes that rising competition from domestic as well as foreign e-commerce companies poses a serious risk to Alibaba. Additionally, the regulatory concerns and higher costs associated with new initiatives remain major problems.
At the same time, Alibaba is benefiting from solid momentum across the Core Commerce segment driven by its growing China and International Commerce businesses. Further, its robust New Retail strategy which is gaining strong traction in the market remains a major positive. This is aiding growth in Tmall Import, Freshippo and Intime Department Stores. Furthermore, well-performing Cainiao logistics services are contributing well.
Netflix shares have gained +13.4% in the last six months against the Zacks Broadcast Radio and Television industry’s gain of +1.4%. The Zacks analyst believes that Netflix is dominating the streaming space, courtesy of its diversified content portfolio, which is attributable to heavy investments in the production and distribution of localized, foreign-language content. User-friendly features like Downloads For You are key positives. The launch of low-priced mobile plans is likely to expand Netflix’s subscriber base in Asia Pacific.
However, rising competition from Apple, Amazon, HBO Max, Disney+ and Peacock is a major headwind. Netflix’s leveraged balance sheet and higher streaming obligation is also a concern.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Johnson & Johnson, Alibaba, Netflix, Qualcomm and Enbridge
For Immediate Release
Chicago, IL – October 5, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Johnson & Johnson (JNJ - Free Report) , Alibaba Group Holding Limited (BABA - Free Report) , Netflix, Inc. (NFLX - Free Report) , QUALCOMM Incorporated (QCOM - Free Report) and Enbridge Inc. (ENB - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for J&J, Alibaba and Netflix
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, Alibaba, and Netflix. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of Johnson & Johnson have underperformed the Zacks Large Cap Pharmaceuticals industry over the year-to-date period (+1.9% vs. +8.0%). J&J faces numerous lawsuits, which allege personal injuries to patients caused by the use of its products. The Zacks analyst believes that these lawsuits have resulted in uncertainties.
However, J&J’s diversification makes it relatively resilient amid macroeconomic turmoil. The Pharma unit is performing at above-market levels, supported by increased penetration and new indications of blockbuster drugs, Imbruvica, Darzalex and Stelara.
Its Medical Devices segment is also demonstrating a strong recovery after its sales were hurt in the early stages of the pandemic. J&J is also making rapid progress with its pipeline and line extensions.
(You can read the full research report on Johnson & Johnson here >>>)
Shares of Alibaba have underperformed the Zacks Internet – Commerce industry over the year-to-date period (-38.0% vs. -30.9%). The Zacks analyst believes that rising competition from domestic as well as foreign e-commerce companies poses a serious risk to Alibaba. Additionally, the regulatory concerns and higher costs associated with new initiatives remain major problems.
At the same time, Alibaba is benefiting from solid momentum across the Core Commerce segment driven by its growing China and International Commerce businesses. Further, its robust New Retail strategy which is gaining strong traction in the market remains a major positive. This is aiding growth in Tmall Import, Freshippo and Intime Department Stores. Furthermore, well-performing Cainiao logistics services are contributing well.
(You can read the full research report on Alibaba here >>>)
Netflix shares have gained +13.4% in the last six months against the Zacks Broadcast Radio and Television industry’s gain of +1.4%. The Zacks analyst believes that Netflix is dominating the streaming space, courtesy of its diversified content portfolio, which is attributable to heavy investments in the production and distribution of localized, foreign-language content. User-friendly features like Downloads For You are key positives. The launch of low-priced mobile plans is likely to expand Netflix’s subscriber base in Asia Pacific.
However, rising competition from Apple, Amazon, HBO Max, Disney+ and Peacock is a major headwind. Netflix’s leveraged balance sheet and higher streaming obligation is also a concern.
(You can read the full research report on Netflix here >>>)
Other noteworthy reports we are featuring today include Qualcomm and Enbridge.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.